Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|39|5943-5947

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.39, 2016-12, pp. : 5943-5947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NEDD4: A Promising Target for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

gp130: a promising drug target for cancer therapy

By Xu Shili   Neamati Nouri  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1303-1328

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylation: An Attractive Target for Cancer Therapy?

By Al-Janadi Anas   Chandana Sreenivasa R.   Conley Barbara A.  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 369-383

Adis International

Access to resources Recommend Favorite

The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy

By  

Current Medicinal Chemistry, Vol. 15, Iss. 27, 2008-11 ,pp. : 2840-2849

Bentham Science Publishers

Access to resources Recommend Favorite